14997

,

Prix Galien 2010 : winners and finalist candidates of the Prix Galien USA, International, and Pro Bono Humanitarian Awards 2010

Wiley Periodicals

vii, 99 p

Annals of the New York Academy of Sciences; v. 1222

Caption title.

Foreword /Ban Ki-Moon --Prix Galien Pro Bono Humanitarian Award Winner : Philippe Douste-Blazy /Philippe Douste-Blazy --Prix Galien Pro Bono Humanitarian Award Winner : William J. Clinton /William J. Clinton --Advances in the diagnosis of respiratory tract infections : role of the LuminexTAG respiratory viral panel /Nancy Krunic ... [et al.] --Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine /Michelle G. Goveia ... [et al.] --Novartis Malaria Initiative : best practice example of pharmaceutical industryʹs engagement in the fight against malaria /Gilbert Lefaevre, Anne Claire Marrast, and Heiner Grueninger --Development of the IL-12/23 antagonist ustekinumab in psoriasis : past, present, and future perspectives /Newman Yeilding ... [et al.] --Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting /Richard Hargreaves ... [et al.] --Linezolid, the first oxazolidinone antibacterial agent /Karen L. Leach ... [et al.] --The development of romiplostim for patients with immune thrombocytopenia / Graham Molineux --The discovery and development of rivaroxaban /Frank Misselwitz, Scott D. Berkowitz, and Elisabeth Perzborn --A review of the history, properties, and use of the immunomodulatory compound lenalidomide /Jerome B. Zeldis ... [et al.] --Raltegravir : the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium /Bach-Yen T. Nguyen ... [et al.] --Innovation in coronary artery disease and heart failure : clinical benefits of pure heart rate reduction with ivabradine /Emmanuel Canet, Guy Lerebours, and Jean-Paul Vilaine.

AU New York Academy of Sciences.

744

QV

9781573318358 ,

Includes bibliographical references.

c2011